Curian Capital’s Exact Sciences EXAS Stock Holding History

Curian Capital’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-13,046	Closed	-$253K	–	597
2014 Q3	$253K	Sell	13,046 -16,899	-56%	-$310K	﹤0.01%	575
2014 Q2	$510K	Buy	29,945 +1,840	+7%	+$25.3K	0.01%	552
2014 Q1	$398K	Buy	+28,105	New	+$380K	0.01%	571

Other funds holding EXAS

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

JPCCM

J&P (China) Capital Management Hong Kong, China $586M AUM 82.64% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Curian Capital's EXAS Position: Q4 2014 in Review

Curian Capital sold out of Exact Sciences (EXAS) in Q4 2014, closing a stake of 13,046 shares — an estimated $253K sold.

Curian Capital first reported a position in EXAS in Q1 2014 and held it in 3 quarters. The position peaked at $510K in Q2 2014. 198 funds tracked by Wall St. Rank hold EXAS as of Q4 2014.

Curian Capital reported no remaining Exact Sciences position as of Q4 2014 after selling out during the quarter.
Curian Capital sold 13,046 Exact Sciences shares in Q4 2014, an estimated $253K.
Curian Capital first reported a position in Exact Sciences in Q1 2014 and held it in 3 quarters.
Curian Capital's Exact Sciences position peaked at $510K in Q2 2014.
198 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2014.

Based on Curian Capital's 13F filing for Q4 2014, filed 11 Feb 2015.